GSA Capital Partners’s Regencell Bioscience RGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$242K Buy
+38,925
New +$225K 0.01% 1501
2026
Q2
– Sell
-31,569
Closed -$803K – 2105
2026
Q1
$803K Buy
+31,569
New +$893K 0.05% 594

Other funds holding RGC

GSA Capital Partners's RGC Position: Q3 2026 in Review

GSA Capital Partners opened a new position in Regencell Bioscience (RGC) in Q3 2026: 38,925 shares worth $242K. The stake represents 0.01% of the portfolio and ranks #1501 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in RGC as recently as Q1 2026.

GSA Capital Partners first reported a position in RGC in Q1 2026 and has held it in 2 quarters since. The position peaked at $803K in Q1 2026. 31 funds tracked by Wall St. Rank hold RGC as of Q3 2026.

  • GSA Capital Partners held 38,925 shares of Regencell Bioscience worth $242K as of Q3 2026.
  • Regencell Bioscience was a new GSA Capital Partners position in Q3 2026.
  • Regencell Bioscience made up 0.01% of GSA Capital Partners's portfolio in Q3 2026, its #1501 holding.
  • GSA Capital Partners first reported a position in Regencell Bioscience in Q1 2026 and has held it in 2 quarters since.
  • GSA Capital Partners's Regencell Bioscience position peaked at $803K in Q1 2026.
  • 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.

Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.